Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Ascorbic acid 2件: Ascorbic acid; Vitamin C1件: Ascorbic acid 💬 --8件: 10, 97, 192, 206, 210, 211, 212, 298 💬
2 Baclofen 1件: Baclofen1件: Baclofen 💬 2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
3 CLZ-2002 1件: CLZ-2002---1件: 10 💬
4 Engensis 1件: Engensis---2件: 2, 10 💬
5 Epalrestat 1件: Epalrestat1件: Epalrestat 💬 1件: AKR1B 💬 5件: Folate biosynthesis, Fructose and mannose metabolism, Galactose metabolism, Glycerolipid metabolism, Pentose and glucuronate interconversions 💬1件: 10 💬
6 Mexiletine 2件: Mexiletine; Mexiletine hydrochloride2件: Mexiletine hydrochloride ,
Mexiletine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 1, 2, 10, 113, 114 💬
7 Naltrexone 2件: Naltrexone; Naltrexone hydrochloride2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬12件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
8 Sorbitol 2件: D-glucitol; Sorbitol1件: Sorbitol solution 💬 --3件: 10, 28, 97 💬
9 Ubidecarenone 2件: Coenzyme Q10; COQ101件: Ubidecarenone 💬 --14件: 2, 5, 6, 8, 10, 46, 57, 86, 96, 107, 113, 193, 214, 215 💬
10 Ulipristal 1件: Ulipristal acetate2件: Ulipristal ,
Ulipristal acetate 💬 		1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 10 💬